FIELD: medicine.
SUBSTANCE: in the base of verruga or hemangioma 40-60 minutes prior to cryolysis 2-4 ml (250-500 mg) of 12.5% dicynon solution is injected.
EFFECT: enhancement of destructive effect of cryolysis with simultaneous reduction of its exposure and increase of its controllability.
1 ex, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING HEMANGIOMAS OF DIFFERENT TYPES | 2002 |
|
RU2233136C1 |
| METHOD OF TREATING BENIGN SKIN MASS IN CHILDREN | 2008 |
|
RU2387447C1 |
| METHOD OF TREATING BENIGN VASCULAR SKIN GROWTH IN CHILDREN | 2009 |
|
RU2438613C2 |
| METHOD OF TREATING HEMANGIOMAS OF COMPLICATED ANATOMICAL LOCALISATION | 2011 |
|
RU2465026C1 |
| METHOD OF TREATING SKIN AND SOFT TISSUE HEMANGIOMAS IN INFANTS | 2010 |
|
RU2464053C2 |
| METHOD FOR APPLYING CRYOGENIC TREATMENT OF PATHOLOGICAL FOCI | 2003 |
|
RU2246280C1 |
| SURGICAL METHOD FOR TREATING RACEMOSE EXTERNAL EAR HEMANGIOMA CASES | 2004 |
|
RU2276969C2 |
| METHOD FOR CRYODESTRUCTION OF SKIN TUMORS | 2022 |
|
RU2807605C1 |
| METHOD OF TREATING LARGE CAVERNOUS HEMANGIOMA OF CHILDREN JAW-FACE REGION | 0 |
|
SU952224A1 |
| METHOD OF TREATING PLANTAR WARTS | 2012 |
|
RU2531526C2 |
